vimarsana.com

Page 205 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit

Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit News provided by Share this article Share this article SAN FRANCISCO, Feb. 16, 2021 /PRNewswire/  Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the BofA Securities Animal Health Virtual Summit on February 25.    Dr. Richard Chin, Chief Executive Officer, will present via webcast at 10.50am ET and be available for virtual one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones. An archived version of the above webcast will be available for 30 days on the KindredBio website.

Cannabics Pharmaceuticals in-vivo Study concludes with a 33% Lower Tumor Volume in Mice Treated with Company s Proprietary Drug Candidate for Colorectal Cancer

Study design and results: Both the experimental and the control groups were inoculated with human colorectal cancer cells. Daily doses of intraperitoneal (IP) delivery of RCC-33 or sham control were initiated on day 5. Differences in tumor volume between the two groups were first observed after 5 days of treatment (day 10). Previously published interim results showing a 27% reduction in tumor volume were recorded after 12 days of treatment (day 17), with p value ≤ 0.022. The study was concluded after 16 days of treatment (day 21) when a member of the control group reached a predetermined tumor size. Final results recorded a significant and robust 33% reduction in tumor volume in RCC-33 treated mice in comparison with the control group, p value ≤0.016.

Essent Biologics Announces Derek Mathers as Head of Business Development

Essent Biologics Announces Derek Mathers as Head of Business Development News provided by Share this article Share this article CENTENNIAL, Colo., Feb. 16, 2021 /PRNewswire/  Essent Biologics™, a nonprofit biotechnology company providing low passaged primary cells, origin tissue, scaffolds and data to advance regenerative medicine research, today announced the appointment of Derek Mathers as Head of Business Development. Essent Biologics Announces Derek Mathers as Head of Business Development Prior to his role with Essent, Derek served as Director, Strategic Accounts for Advanced Solutions Life Sciences (ASLS), driving revenue through global 3D bioprinting partnerships with leading life science companies. Before ASLS, Derek led global sales at Worrell, where he consulted with leading healthcare companies to design, test and manufacture complex medical devices. While at Worrell, Derek also taught night classes as an adjunct professor of 3D Printing at the University of Minn

Community Healthcare Trust Announces Results for the Three Months Ended December 31, 2020

Community Healthcare Trust Announces Results for the Three Months Ended December 31, 2020 News provided by Share this article Share this article FRANKLIN, Tenn., Feb. 16, 2021 /PRNewswire/  Community Healthcare Trust Incorporated (NYSE: CHCT) (the Company ) today announced results for the three months ended December 31, 2020. The Company reported net income for the fourth quarter of approximately $5.2 million, or $0.21 per diluted common share. Funds from operations and adjusted funds from operations ( AFFO ) for the three months ended December 31, 2020 totaled $0.53 and $0.56, respectively, per diluted common share.  Highlights include: During the fourth quarter of 2020, the Company issued, through its at-the-market offering program ( ATM Program ), 480,592 shares of common stock at an average gross sales price of $47.65 per share and received net proceeds of approximately $22.4 million at an approximate 3.64% current equity yield.

Flo Health Surveyed nearly 3,500 Women to Find out how the Pandemic Has Impacted Sexual Desire, Relationship Quality, and Mental Health

Flo Health Surveyed nearly 3,500 Women to Find out how the Pandemic Has Impacted Sexual Desire, Relationship Quality, and Mental Health Survey Shows Sexual Desire Dips Among Cohabiting Couples, and Rises Among Couples Living Solo Flo Medical Board Member & Sex Therapist, Jordan Rullo PhD Explains Why News provided by Share this article Sexual Desire Declines Among Cohabiting Couples; Increases Among Solo-Living Couples Relationship Quality Rises Among Cohabiting Couples; Not the Case Among Solo-Living Couples Stress, Sensitivity, and Loneliness on the Rise; Flo offers Free Course, Sex Ed for Grownups Flo Health Inc., the leading female health and wellbeing mobile app used by over 160M people around the world, today unveiled findings highlighting the impact the pandemic has had on women s relationships since the start of lockdown, unearthing insights around shifts in sexual desire, partner interaction, and overall mental and emotional wellbeing. The external survey polled a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.